Drug Information
注射用磷罗拉匹坦帕洛诺司琼
瑞坦宁
注射剂
磷罗拉匹坦218mg与盐酸帕洛诺司琼0.25mg（按C₁₉H₂₄N₂O计）
化学药品
May 27, 2025
Company Information
Applicant Company
厦门市海沧区翁角西路2036号厦门生物医药产业园A19号楼一层之五十三
Manufacturing Company
厦门市海沧区翁角路308号6号楼二层
NMPA Approval
Fosrolapitant and Palonosetron Hydrochloride for Injection
MedPath
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.